article · AIDS

Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics

Elizabeth Zaniewski
Aggrey Semeere
Brenda Crabtree‐Ramírez
Moussa Seydi
Jonathan Euvrard
Rossana Ditangco
Jacqueline Huwa
Sarah Obatsa
Anchalee Avihingsanon
Dominique Nsonde
Supattra Rungmaitree
Ellen Brazier
Carina César
Veronika Skrivankova
Tavitiya Sudjaritruk
Sanjay Mundhe
Brian Eley
Albert Minga
Winnie Muyindike
Peter Vanes Ebasone
Thierry Tiendrebeogo
Geoffrey Fatti
Hans Prozesky
Gad Murenzi
Sandra Wagner Cardoso
Daisy Maria Machado
Henri Chenal
Nosisa Sipambo
Karl‐Günter Technau
Joseph Muleebwa
Christelle Twizere
Eugène Messou
Joseph Odhiambo
Patricia Lelo
Marie Ballif

20246 citationsOpen accessUniversity of the Witwatersrand

Abstract

Dolutegravir-based ART was rolled out at nearly all IeDEA clinics in LMICs, yet many switched persons to dolutegravir without recent viral load testing and drug resistance testing was rarely performed. Without such testing, drug resistance among persons switching to dolutegravir may go undetected.

Research topics

HIV/AIDS Research and Interventions
HIV/AIDS drug development and treatment
HIV Research and Treatment

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1097/qad.0000000000004007

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.